H
Henk W.R. Schreuder
Researcher at Utrecht University
Publications - 61
Citations - 2521
Henk W.R. Schreuder is an academic researcher from Utrecht University. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Ovarian cancer. The author has an hindex of 18, co-authored 58 publications receiving 1901 citations. Previous affiliations of Henk W.R. Schreuder include University Medical Center Utrecht.
Papers
More filters
Journal ArticleDOI
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Willemien J. van Driel,Simone N. Koole,Karolina Sikorska,Jules H. Schagen van Leeuwen,Henk W.R. Schreuder,Ralph H. Hermans,Ignace H. J. T. de Hingh,Jacobus van der Velden,Henriette J. G. Arts,Leon F.A.G. Massuger,Arend G. J. Aalbers,Victor J. Verwaal,Jacobien M. Kieffer,Koen Van de Vijver,Harm van Tinteren,Neil K. Aaronson,Gabe S. Sonke +16 more
TL;DR: Among patients with stage III epithelial ovarian cancer, the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery resulted in longer recurrence‐free survival and overall survival than surgery alone and did not result in higher rates of side effects.
Journal ArticleDOI
Training and learning robotic surgery, time for a more structured approach: a systematic review
TL;DR: Training and learning robotic surgery, time for a more structured approach: a systematic review of current approaches is reviewed.
Journal ArticleDOI
Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
C. Nomden,Astrid A.C. De Leeuw,Judith M. Roesink,Robbert J.H.A. Tersteeg,Marinus A. Moerland,Petronella O. Witteveen,Henk W.R. Schreuder,Eleonore B.L. van Dorst,Ina M. Jürgenliemk-Schulz +8 more
TL;DR: (Chemo-) radiation and MR-IGABT with tandem-ovoid applicators result in high LC and promising survival rates with reasonable morbidity.
Journal ArticleDOI
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Mariëtte I.E. van Poelgeest,Marij J. P. Welters,Renee Vermeij,Linda F. M. Stynenbosch,Nikki M. Loof,Dorien M A Berends-van der Meer,Margriet J. G. Löwik,Ineke E. Hamming,Edith M G van Esch,Bart W. J. Hellebrekers,Marc van Beurden,Henk W.R. Schreuder,Marjolein J. Kagie,J. Baptist Trimbos,Lorraine M. Fathers,Toos Daemen,Harry Hollema,A. Rob P. M. Valentijn,Jaap Oostendorp,J Hanneke N G Oude Elberink,Gert Jan Fleuren,Tjalling Bosse,Gemma G. Kenter,Theo Stijnen,Hans W. Nijman,Cornelis J. M. Melief,Sjoerd H. van der Burg +26 more
TL;DR: It is confirmed that clinical efficacy of ISA101 vaccination is related to the strength of vaccine-induced HPV16-specific T-cell immunity and is an effective therapy for HPV 16-induced high-grade VIN/VaIN.
Journal ArticleDOI
Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: A randomized controlled trial
Marianne J. Rutten,Hannah S. van Meurs,Roelien van de Vrie,Katja N. Gaarenstroom,Christiana A. Naaktgeboren,Toon Van Gorp,Henk G. ter Brugge,Ward Hofhuis,Henk W.R. Schreuder,Henriette J. G. Arts,Petra L.M. Zusterzeel,Johanna M.A. Pijnenborg,Maarten van Haaften,Guus Fons,Mirjam J. A. Engelen,Erik A. Boss,M. Caroline Vos,Kees G. Gerestein,Eltjo M.J. Schutter,Brent C. Opmeer,Anje M. Spijkerboer,Patrick M.M. Bossuyt,Ben W.J. Mol,Gemma G. Kenter,Marrije R. Buist +24 more
TL;DR: In women with a plan for PCS, these data suggest that performance of diagnostic laparoscopy first is reasonable and that if cytoreduction to < 1 cm of residual disease seems feasible, to proceed with PCS.